nejm.org/doi/full/10.10…
This study represents a breakthrough for our patients. So grateful for the chance to help lead this trial with an amazing team.
Sahil A. Parikh, MD
297 posts
Sahil A. Parikh, MD
@sahilparikhmd
Interventional Cardiologist, Vascular Medicine, Clinician Educator and Clinical Researcher, Husband/Father, Friend. My views only; not medical advice.
- Congratulations @sanjum and our Endovascular Center Team for earning a prestigious AHA grant entitled "A Comprehensive Assessment of Arterial and Venous Thrombotic Complications in Patients with COVID-19" newsroom.heart.org/news/12-scient… @ajaykirtane @crfheart
- Tremendous multi-center collaborative effort by a very dedicated group of colleagues and mentors. This is the beginning of our understanding of this disease. #COVID19 @EDriggin @DrJennHaythe @MVMadhavanMD @ajaykirtane @GreggWStone @bbikdeli @JoshuaBeckmanMD @hmkyaleToday in #JACC: #COVID19 may have both direct and indirect effects in #CVD. In a new State-of-the-Art Review, @MVMadhavanMD, @sahilparikhmd et al. discuss CV considerations for patients (with and without the #coronavirus), and health care workers/systems. bit.ly/3b7NyqU
- More guidance on Cath Lab related issues during #COVID19 pandemic from our SCAI ELM group. More to come from this group of interventional cardiologists and @SCAI @SrihariNaiduMD @mszerlip scai.org/Assets/a861469…
- Hope to see you there next Sunday! LBTs, live cases and three outstanding sessions on femoropopliteal disease, CLI, and really interesting case conference. @roblookstein @EricSecemskyMD @ehrin_armstrongWhat is @sahilparikhmd looking forward to at TCT Connect? “A five-hour dedicated program for endovascular specialists from all over the world!” Join us for the TCT #endovascular program on Sunday, October 18. #TCTConnect #TCT2020 tctconnect.com
00:00 - Big day at #TCTConnect tomorrow dedicated to Endovascular therapy and Fellows! @ajaykirtane @EricSecemskyMD @roblookstein @PK_MountSinai @PSchneiderMD @VEITHsymposium @TCTConference
- UPDATE: Treatment of Peripheral Arterial Disease with Paclitaxel-Coated Balloons and Paclitaxel-Eluting Stents Potentially Associated with Increased Mortality - Letter to Health Care Providers fda.gov/MedicalDevices…. Science must lead the way.
- Live case of complex LM bifurcation from Columbia University Irving Medical Center - lucky that I get to learn from my brother Manish and buddies Dimitrios Karmpaliotis and @ajaykirtane every day. #TCT2019 #everycaseisalivecase
- First Transradial #RangerDCB case HT @sahilparikhmd the low profile and 150cm shaft length opens up new approaches to treat patients #Radial #Pedal #PAD #RangerDCB #EvidenceBasedMedicine
- UPDATE: Risk of Mortality Associated with Paclitaxel-Coated Devices to Treat Peripheral Arterial Disease is No Longer Supported Based on Data and Analyses - Letter to Health Care Providers fda.gov/medical-device…
- Proud to be a member of this incredible team! @crfheart @MartyMleon @GreggWStone @Drroxmehran @jgranadacrf @triciarawh @VEITHsymposium @TCTConferenceThis Post is from an account that no longer exists. Learn more
- Breaking at #VEITH2019: Announcing the LIFE-BTK pivotal IDE clinical trial to evaluate the safety & effectiveness of ESPRIT BTK, a new everolimus eluting bioresorbable scaffold intended for treating critical limb ischemia! Read about the #innovativetech: linkedin.com/pulse/research…
- @sahilparikhmd keynote on CLI #viva19 Underscores importance of team based approach to optimize quality and outcomes @BEST_CLI
- My gratitude to our incredible fellows who have worked tirelessly during the height of the surge of #COVID19 to stem the tide. We are here to support your training now and in the future. We are in your debt. @DrTGupta @MatthewTFinn @IngrassiaMD @ajaykirtaneReplying to @DrTGuptaFinally, 29% of PDs and 33% of IC fellows felt that there should either be an extension of training or a period of on-the-job mentorship for the current class of IC fellows. Thoughts? @ajaykirtane @tnazifMD @sahilparikhmd @SusheelKodaliMD @anna_bortnick @stentdoc1 @JWMoses
